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ABSTRACT
In this study we examine the consequences of altering Hand1
phosphoregulation in the developing neural crest cells (NCCs) of
mice. Whereas Hand1 deletion in NCCs reveals a nonessential
role for Hand1 in craniofacial development and embryonic survival,
altering Hand1 phosphoregulation, and consequently Hand1
dimerization affinities, in NCCs results in severe mid-facial clefting
and neonatal death. Hand1 phosphorylation mutants exhibit a non-
cell-autonomous increase in pharyngeal arch cell death accompanied
byalterations inFgf8 andShh pathwayexpression. Together, our data
indicate that the extreme distal pharyngeal arch expression domain of
Hand1 defines a novel bHLH-dependent activity, and that disruption
of established Hand1 dimer phosphoregulation within this domain
disrupts normal craniofacial patterning.
KEY WORDS: Hand1, bHLH, Craniofacial development,
Transcription, Dimerization, Phosphorylation, Neural crest
INTRODUCTION
Neural crest cells (NCCs) are a multipotent cell population that
specifies within the dorsal lip of the neural tube and subsequently
delaminates, migrates and populates the pharyngeal arches (PAs),
before ultimately differentiating into a wide spectrum of structures/
tissues along the anterior-posterior (AP) axis of vertebrate embryos
(Clouthier et al., 2010; Minoux and Rijli, 2010; Ruest and Clouthier,
2009; Trainor, 2005; Gitton et al., 2010). The NCCs that migrate into
the first and second PAs are primarily responsible for orchestrating
craniofacial development. Well-integrated signaling programs
function through transcription factors to define tissue patterning and
NCC differentiation. The complex signals that govern craniofacial
morphogenesis involve a number of input pathways, including Fgf,
Shh, Wnt, Bmp, Pdgf, retinoic acid (RA) and endothelin signaling
(Abe et al., 2008; Abzhanov and Tabin, 2004; Clouthier et al., 2003;
Jiang et al., 2006; Kurihara et al., 1995; Macatee et al., 2003).
Dysregulation of NCC migration, proliferation and patterning can
result in craniofacial abnormalities observed in numerous human
syndromes (Chai and Maxson, 2006; Jiang et al., 2006; Noden and
Trainor, 2005; Clouthier et al., 2013). Indeed, cleft lips and cleft
palates are among the most common congenital defects observed in
newborns. Understanding the signaling pathways and downstream
transcription factors that govern craniofacial morphogenesis is crucial
in defining the etiology of these common congenital defects.
Members of the basic helix-loop-helix (bHLH) transcription factor
superfamily play dominant roles in cell specification, differentiation
and tissue patterning throughout embryonic development (Massari
andMurre, 2000). bHLH transcription factors affect transcription by
forming either a bHLH homo- or heterodimer and by binding
DNAvia a cis-element termed E-box. Loss-of-function studies in the
Twist sub-class of bHLH factors, which include Twist1, Twist2,
Hand1 andHand2 (Barnes andFirulli, 2009), reveal that these factors
play key roles in craniofacial morphogenesis. Targeted disruption of
Twist1 in NCCs leads to defects in upper and lower jaw development
(Bildsoe et al., 2009). NCC-specific deletion of Hand2 results in
disruption of lower jaw and tongue development (Barron et al.,
2011). These factors appear highly conserved during vertebrate
evolution (Barnes and Firulli, 2009) and probably play similar
roles in human facial development. Indeed, human mutations in
TWIST1 cause Saethre–Chotzen syndrome (SCS). In addition to
craniosynostosis, palatal anomalies are commonly observed in SCS
patients (Stoler et al., 2009).
Compelling evidence shows that Twist family bHLH factors
mediate biological function by dimer choice (Castanon et al., 2001;
Firulli et al., 2003, 2005, 2007). Dimer choice is regulated, in part, by
a threonine and serine pair that is evolutionarily conserved among all
Twist family members. Mimicking Hand1 hypophosphorylation
through mutations in residues T107 and S109 enhances homodimer
formation, whereas mimicking Hand1 phosphorylation at T107 and
S109 enhances formation of E-protein heterodimers (Firulli et al.,
2003). Indeed, changes in bHLH dimer choices affect craniofacial
development (Connerney et al., 2006). Dysregulation of Twist1
phosphorylation at these threonine and serine residues causes SCS
(Cai and Jabs, 2005; Firulli et al., 2005). Dimerization of Twist-
family bHLH factors is governed by their co-expressionwithin a cell,
their colocalization within the nucleus, their level of relative
expression and the phosphorylation of the conserved threonine and
serine residues within Helix I of the bHLH domain (Firulli and
Conway, 2008; Firulli et al., 2003, 2005, 2007). Overexpression
studies alter the stoichiometry of this bHLH pool. Thus, to validate
the consequences of dysregulating this post-translational control
mechanism within the bHLH dimer pool in vivo, it is essential to
manipulate phosphorylation but not expression levels.
By contrast to the dominant roles exhibited byTwist1 andHand2 in
craniofacial development, the related factor Hand1, although
expressed within the distal most NCC-derived PA mesenchyme
(Clouthier et al., 2000), shows no observable phenotypes in NCC
loss-of-function analysis. However, there is a clear gene dosage effect
when Hand1 NCC conditional-null mice are placed on a Hand2
heterozygous background (Barbosa et al., 2007). This suggests a
crucial Hand gene dosage that, when disrupted, perturbs the bHLH
dimer poolwithin cranialNCCs, resulting inmorphogenic defects. To
test whether Hand1 phosphorylation-dependent dimer regulationReceived 30 December 2013; Accepted 29 May 2014
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alters the composition of the bHLH dimer pool, which influences
craniofacial morphogenesis, we engineered two Hand1 conditional-
activation knock-in alleles designed to either mimic Hand1
hypophosphorylation by replacing both threonine 107 and serine
109 with alanines (PO4−), or to mimic Hand1 hyperphosphorylation
by replacing these residues with aspartic acids (PO4+). Activation of
these phospho-mutant alleles within NCCs results in severe mid-
facial clefting.Mutant embryos displayabnormal cell deathwithin the
developing PAs, resulting in reduced outgrowth of the maxillary
processes and aberrant craniofacial development. The majority of
structural defects occur within tissues where Hand1 is not expressed
and where Hand1-lineage cells are not detected. Gene expression
analyses show that both fibroblast growth factor 8 (Fgf8) and sonic
hedgehog (Shh) signaling pathways are affected. Interestingly,
removing the wild-type Hand1 allele on both the Hand1PO4− and
Hand1PO4+ backgrounds results in reduced levels of cell death and
improved craniofacial development. Together, these results show that,
although Hand1 is dispensable for development of craniofacial
structures, a misregulation of Hand1 dimer choice within the NCC-
derived distal PA ectomesenchyme disrupts the function of other
factors required for craniofacial morphogenesis. These findings
suggest that Hand1 and its putative bHLH dimer partners
transcriptionally control one or more of the theorized cap signals
central to the ‘Hinge and Caps’ model of PA patterning (Depew and
Compagnucci, 2008; Fish et al., 2011).
RESULTS
Hand1 phospho-mutant expression within the PAs results in
pronounced mid-facial clefts
To understand the role ofHand1 phosphoregulationwithinNCCs, we
engineered two targeted conditionally active Hand1 alleles, wherein
residues T107 and S109were replaced with either alanines (PO4−) or
aspartic acids (PO4+; Fig. 1A). By incorporating a Stop-flox cassette
containing a neomycin resistance gene downstream of the Hand1
transcriptional start site, but upstream of the Hand1-initiating
methionine, we were able to create null, conditional phospho-
mutant Hand1 alleles. In tissues where the Cre recombinase and
endogenousHand1 expression directlyoverlap, the Stop-flox cassette
is removed, allowing expression of the Hand1PO4− or Hand1PO4+
mutant alleles. Hand1 expression within NCC-derived mesenchyme
of the distal PAs is first detectable at E9.5. Expression cannot be
detected at E9.0 using the sensitiveHand1lacZ knock-in allele (Firulli
et al., 1998; Fig. 1B-E). Hand1 expression initiates in the most
posterior/caudal portions of the distal PAbefore expanding anteriorly/
rostrally, but not laterally. At E13.5,Hand1-expressing cells mark the
medial tongue (t) and fusion point of the two mandibular halves (md;
Fig. 1F,G). Although Hand1-lineage analysis reveals minor lateral
spreading of these distal cells, Hand1 expression is lost as the cells
move laterally from the midline. Craniofacial structures of the
calvarium do not express Hand1 or contain Hand1 lineage cells
(Barnes et al., 2010).
We tested the efficacy of our conditional Hand1 phospho-mutant
alleles by activating mutant expression in NCCs using theWnt1-Cre
allele (Danielian et al., 1998). Whole-mount in situ hybridization
(ISH) of Hand1 detects distal expression in the forming PAs of
control embryos (Fig. 1H-J). To demonstrate that the conditional
alleles show the expectedHand1 spatio-temporal pattern, we crossed
both the Hand1PO4− and Hand1PO4+ mutant alleles onto the Hand1
conditional (Hand1fx) allele (Barbosa et al., 2007; McFadden et al.,
2005), and then recombined both conditional alleles in NCCs using
the Wnt1-Cre allele. Using Hand1PO4−/fx;Wnt1-Cre(+) and
Hand1PO4+/fx;Wnt1-Cre(+) embryos, we demonstrate that mRNA
expression from either of the Hand1 phospho-mutant alleles is
indistinguishable fromwild-typeHand1 or theHand1lacZ expression
by Hand1 ISH (Fig. 1I,J). However,Wnt1-Cre-mediated expression
of both Hand1 phospho-mutant alleles results in neonatal death
accompanied by 100% penetrant mid-face clefts (Fig. 1L-N).
To determine when we could first detect a facial phenotype,
we collected mutant embryos from timed pregnancies between
E10.5 and E19.5. Hand1+/PO4−;Wnt1-Cre(+), Hand1+/PO4+;
Wnt1-Cre(+), Hand1PO4−/fx;Wnt1-Cre(+) and Hand1PO4+/fx;
Wnt1-Cre(+) phenotypes are first morphologically identifiable at
E10.5, wherein distances between the lateral nasal prominences
(lnp) and the olfactory pits (op, black line) are extended and
maxillary processes (mp) are symmetrically reduced in size
(supplementary material Fig. S1). As development proceeds, the
extent of this phenotype becomes more evident. Surprisingly,
removal of the wild-type Hand1 allele reduces the severity of both
hypophosphorylated and phosphorylation-mimicking phenotypes.
Histological analysis at E14.5 shows that structures such as tooth
primordia (tp), Meckel’s cartilage (mc) and nasal cavities (nc) form
normally in the Hand1 phospho-mutant embryos (supplementary
material Fig. S2). The nasal capsule is also present but is deviated
down the midline with the rest of the facial structures. By contrast,
Hand1 phospho-mutant heterozygotes [Hand1+/PO4−;Wnt1-Cre(+)
and Hand1+/PO4+;Wnt1-Cre(+)] lack a patent nasal septum (does
not fuse at the midline; ns; black asterisk; supplementary material
Fig. S2G,I). Furthermore, the palatal shelves (ps) are not fused,
resulting in aberrant communication between the nasopharynx and
oral cavity (supplementary material Fig. S2B,D). Single-copy point
mutants [Hand1PO4−/fx;Wnt1-Cre(+) andHand1PO4+/fx;Wnt1-Cre(+)]
show improvement in nasal septum development (supplementary
material Fig. S2H,J), and in the case of Hand1PO4+/fx;Wnt1-Cre(+)
embryos, palatal shelf fusion is observed in mixed penetrance,
although clefting is still fully penetrant (supplementary material
Fig. S2E,J).
We next employed micro-computed tomography (micro-CT)
scans of heads from P0 Hand1+/PO4−;Wnt1-Cre(+), Hand1+/PO4+;
Wnt1-Cre(+), Hand1PO4−/fx;Wnt1-Cre(+) and Hand1PO4+/fx;
Wnt1-Cre(+) embryos. In Hand1PO4−/+ mutant embryos, structural
defects were observed throughout the skull. On lateral view, the
premaxilla (pm, dark purple) is shortened, and both the overlying
nasal bone (n, green) and a portion of the maxilla (mx, blue) closest to
the frontal bone (f, red) are missing (Fig. 1L). The jugal bone ( j, dark
red), the middle bone of the zygomatic arch (with the others being the
zygomatic processes of the maxilla and squamosal bones), is
hypoplastic, and the squamosal bone (sq, light purple) is absent
(Fig. 1K). The proximal mandible (md, bronze) is also hypoplastic. In
dorsal view (Fig. 1L), the interparietal (i, turquoise) and frontal bones
are hypoplastic, the latter leading to a large gap between the frontal
bones. The upper incisors (magenta, white arrow) are readily visible
due to this hypoplasia and the absence of the nasal bone. Both sagittal
sutures are also aberrantly fused (asterisk). The hypoplasia of the
mandible is more obvious from the dorsal view, with the two halves
failing to meet at the midline. A ventral view (Fig. 1M) reveals more
significant changes to the skull base. Whereas the midline defects
around the premaxilla are obvious, most bones appear hypoplastic.
The basisphenoid (bs, uncolored) and pterygoid bones (pt, uncolored)
are severely underdeveloped, with the missing squamosal bone more
obvious. Also missing is the lamina obturans (the bony portion of the
future alisphenoid that abuts the squamosal bone). In addition,
themidline cleft defect resulted in the failure of the palatine bones and
the palatal processes of the maxilla to fuse (pl, yellow). To examine
cartilage derivatives, we stained E17.0 control and Hand1+/PO4+;
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Fig. 1. Expression and craniofacial phenotypes of Hand1 phospho-mutant mice. (A) Targeting design and Southern blot restriction fragment length
polymorphism (RFLP) analysis of the Hand1PO4− and Hand1PO4+ mutant alleles. (B-G) β-galactosidase staining of Hand1lacZ embryos (hearts removed prior
to staining) at E9.0 (B,C), E9.5 (D,E) and E13.5 (F,G) showing the distal expression of Hand1 initiating within the first arch (marked in B,C as ‘I’) between
E9.0 and E9.5 (black arrow in E). Expression is limited to the most distal arch tissue, which at E13.5 marks the central tongue (t) and mandible (md). (H-J) Whole-
mount ISH showing Hand1 expression within the medical arch mesenchyme in wild type (H) and in Hand1PO4−/fx (I) and Hand1PO4+/fx (J) single copy mutants
(hearts removed prior to hybridization). (K-M) Micro-CT images of P0 skulls from control, Hand1+/PO4−, Hand1PO4−/fx, Hand1+/PO4+ and Hand1PO4+/fx embryos
shown from the right lateral (K), dorsal (L) and ventral (M) sides of the skulls. Abbreviations for row K: i, interparietal bone (turquois); p, parietal bone (light green);
f, frontal bone (red); n, nasal bone (green); sq, squamosal bone (light purple); pm, premaxilla (dark purple); j, jugal bone (dark red); mx, maxilla (blue); md,
mandible (bronze); ty, tympanic bone (uncolored). Abbreviation for row L: i, incisors (magenta, indicated by white arrow). Abbreviations for row M: pl, palatine
bones (yellow); bs, basisphenoid (uncolored); pt, pterygoid bones (uncolored). n≥4 for each genotype. Bone and cartilage staining of control (N) and
Hand1+/PO4− mutant (O). Maxilla, (mx); hyoid (hy).
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Wnt1-Cre(+) embryos with alizarin red and alcian blue to visualize
bone and cartilage, respectively. Compared with control embryos
(Fig. 1N), themalleus and incus (mandibular arch) aswell as the stapes
(second PA) appear normal in Hand1+/PO4+;Wnt1-Cre(+) embryos
(Fig. 1O). However,Meckel’s cartilage (mandibular arch) is truncated
at its originwith themalleus, and the cartilage anlageof the hyoid bone
(second arch) is poorly ossified and deformed at the midline.
Defects in Hand1PO4−/fx;Wnt1-Cre(+) embryos, in which only
the mutant Hand1 allele is present, are less severe. In lateral view
(Fig. 1K), the squamosal, jugal and tympanic ringbones appear
normal, as does the premaxilla and the mandible. The nasal bone is
present but hypoplastic. In dorsal view (Fig. 1L), the midline defects
in the front bones are apparent, as hypoplasia of the nasal bone
allows visualization of the upper incisors. The sagittal sutures
appear normal. In ventral view (Fig. 1M), there is modest
improvement in the pterygoid bones, although the basisphenoid is
still hypoplastic. The size of the lamina obturans and squamosal
bones are also improved compared withHand1+/PO4− embryos. The
trabecular basal plate is also better developed, although there is still
a significant cleft between the palatal processes of the palatine and
maxilla bones and between the two halves of the premaxilla.
In Hand1+/PO4+;Wnt1-Cre(+) embryos, a lateral view shows that
the premaxilla, nasal, and the squamosal bones are better formed,
but are still slightly hypoplastic. The proximal mandible also
appears slightly smaller. In dorsal view, the distal mandible appears
fused at the midline and the sagittal sutures appear normal. By
contrast, the midline cleft in the maxilla appears more severe than
observed in Hand1+/PO4− mutants, with the defect extending into
the parietal bones. The gap between the upper incisors is noticeably
enlarged. Ventral changes in Hand1+/PO4+ mutants are nearly
identical to those observed inHand1+/PO4−mutants. One additional
difference is the absence of at least a portion of the ala temporalis
portion of the alisphenoid.
In lateral view, Hand1PO4+/fx;Wnt1-Cre(+) mutants appear nearly
identical toHand1+/PO+;Wnt1-Cre(+)mutants, although the proximal
mandible is slightly hypoplastic, as is the squamosal bone. On dorsal
view, phenotypes are similar to Hand1+/PO4+ mutants. On ventral
view, themiddle-ear ossicles are either hypoplastic orabsent, although
portions of the alisphenoid appear better developed. Interestingly, the
palatal processes of the palatine and maxilla appear to fuse normally
along the midline, although both structures are smaller than those in
control embryos. The ectopic bone observed in Hand1PO4+/fx;Wnt1-
Cre(+)mutants is not present inHand1+/PO+;Wnt1-Cre(+) embryos.
A detailed measure of bone sizes is shown in supplementary material
Table S1.
Hand1 phospho-mutants exhibit increased cell death within
the PAs
We postulated that the midline defects in facial structures could be the
result of a defect in cellmigration, the inabilityof the structures to fuse,
decreased cell proliferation or increased cell death within the cranial
NCC. We looked at NCC migration by utilizing ROSA26lacZ reporter
lineage-tracing and observed no obvious migration defects for the
NCCs entering the PAs or cardiac outflow tract (supplementary
material Fig. S3). Defects in tissue fusion seem unlikely, as fusion
is observed in the Hand1PO+/fx;Wnt1-Cre(+) mutants (Fig. 1;
supplementary material Fig. S2), and the assessment of the fusion
markers Jagged2 andMmp13 reveal no significant variations between
E14.5 control and Hand1+/PO4−;Wnt1-Cre(+) or Hand1+/PO4+;
Wnt1-Cre(+) embryos (supplementary material Fig. S4). 5-Ethynyl-
2′-deoxyuridine (EdU) incorporation analysis reveals no significant
difference in NCC proliferation between control and all Hand1
phospho-mutant embryos at E9.5 and E10.5 (data not shown). By
contrast, significantly elevated levels of cell death are observed within
the PAs of Hand1 phospho-mutant embryos compared with control
littermates (Fig. 2). At E9.5, whole-mount LysoTracker staining of
control embryos reveals two dorsally localized domains of normal
developmental cell death (black arrows) with low levels of cell death
detected within the PA mesenchyme (Fig. 2A, white arrow). This is
confirmed by section terminal deoxynucleotidyl transferase dUTP
nickend labeling (TUNEL) analysis (Fig. 2C, yellowarrows indicating
developmental cell death). E9.5 Hand1+/PO4−;Wnt1-Cre(+) mutant
embryos exhibit amarked reduction in the developmental dorso-lateral
cell death domainswhile displaying amarked increase in PA cell death
as assayed by both LysoTracker and TUNEL staining (Fig. 2E,G).
Correlating with the less severe clefting phenotype, Hand1PO4−/fx;
Wnt1-Cre(+) mutants display levels of normal dorso-lateral
developmental cell death similar to controls, while at the same time
exhibitingdecreased cell deathwithin thePAmesenchyme (Fig. 2I,K).
Similar findings are observed in Hand1PO+/fx;Wnt1-Cre(+) embryos
(Fig. 2M,O). At E10.5, the extent of cell death within the PA of the
phospho-mutants is reduced when compared with control embryos
(Fig. 2B,D,F,H,J,L,N,P,R,T). Given that the Hand1 expression
domain (Fig. 1) does not directly overlap with the observed domain
of PA cell death, we reasoned that a cell signaling pathway is disrupted
inHand1 phospho-mutant embryos and that the observed craniofacial
phenotypes are generated non-cell autonomously.
Hand1 phospho-mutants show alterations in signaling
pathways that regulate craniofacial formation
During craniofacial formation, numerous signaling pathways intersect
to govern normal morphological patterning and include Fgf, Shh,
Wnt, Bmp and RA signaling (Clouthier et al., 2010; Trainor, 2005).
We first looked at altered RA signaling as Rdh10mutant mice exhibit
similar mid-facial clefting (Sandell et al., 2007). By intercrossing
Hand1 phospho-mutant mice with the RARE-lacZ reporter line
(Rossant et al., 1991), we found that RARE-lacZ patterning was
largely unaffected in bothHand1+/PO4−;RARE-lacZ(+);Wnt1-Cre(+)
andHand1+/PO4+;RARE-lacZ(+);Wnt1-Cre(+) embryos at E10.5 and
E11.5 (supplementary material Fig. S5). Likewise, expression of both
Bmp2 andBmp4 shows no appreciable difference betweenmutant and
control embryos (data not shown).
We next examined Fgf8 expression in control and Hand1 mutant
embryos between E9.5 and E12.5 (Fig. 3). Mouse models that exhibit
variation in Fgf8 gene dosage and Fgf8 gain-of-function studies in
chicks both present withmid-face clefts that are accompanied by early
cell death (Abzhanov andTabin, 2004;Chen et al., 2012;Griffin et al.,
2013; Moon and Capecchi, 2000).Fgf8 expression between E9.5 and
12.5 shows a marked expansion in Hand1 phospho-mutants when
compared with control embryos. Fgf8 expression within the rostral
portion of the first arch, the maxillary processes and surrounding the
nasal pits is expanded and becomes more pronounced over time
(Fig. 3: compare D with H, L, P and T). Levels of Fgf8 expression
appear more persistent in E12.5 mutant embryos where olfactory pit
expression is more robust and expression at the edge of the maxilla is
still visible (Fig. 3D,H,L,P,T, white arrows).
To validate this observation, we next looked at the expression of
sprouty homolog 1 (Spry1) and ets variant 5 (Etv5), both downstream
mediators of Fgf8/FgfR1 signaling (Firnberg and Neubüser, 2002;
Lunn et al., 2007; Minowada et al., 1999; Raible and Brand, 2001), in
Hand1+/PO4−;Wnt1-Cre(+) and Hand1+/PO4+;Wnt1-Cre(+) embryos
at E10.5 (Fig. 4). Similar to Fgf8 expression, Spry1 expression is
expanded around the first PA and surrounding the olfactory pits in both
Hand1+/PO4−;Wnt1-Cre(+) and Hand1+/PO4+;Wnt1-Cre(+) mutants
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when compared with control littermates (Fig. 4B,C, asterisks).
Expression of Etv5 is also expanded. In control embryos, Etv5
mRNA is observed to be more robust within the rostral portion of the
first PA (Fig. 4D, black arrow). In comparison,Etv5 expression within
the first PA of both the Hand1+/PO4− and Hand1+/PO4+ phospho-
mutant embryos shows a clear caudal expansion (Fig. 4E,F, white
arrows). The expression of the FgfR1 shows no significant differences
in expression patterns (Fig. 4G-I). We next performed qRT-PCR on
Fig. 3. Fgf8 craniofacial expression in Hand1 phospho-mutant embryos. Control (A-D), Hand1+/PO4− (E-H), Hand1PO4−/fx (I-L), Hand1+/PO4+ (M-P) and
Hand1PO4+/fx (Q-T) were assayed for Fgf8 expression by whole-mount ISH. Asterisks show enhanced arch expression at E9.5. White bars in B-D,F-H show size
differences in the diameter of the olfactory pits, and black bars in C,D,G,H show differences in distance between the olfactory pits of control and Hand1+/PO4−
mutants. n≥4 for each genotype. White arrows in the bottom row indicate persistent Fgf8 expression.
Fig. 2. Cell death analysis in Hand1 phospho-mutant embryos. Control (A-D), Hand1+/PO4− (E-H), Hand1PO4−/fx (I-L), Hand1+/PO4+ (M-P) and Hand1PO4+/fx
(Q-T) were assayed for cell death using LysoTracker (whole mounts) and TUNEL (sections) at E9.5 and E10.5. Black arrows in whole mount and yellow arrows
in sections mark developmental cell death observed in all controls, white arrows indicate cell death within the PAs that is increased in Hand1 phospho-mutants.
I, first pharyngeal arch; II, second pharyngeal arch. n≥4 for each genotype.
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cDNA reverse transcribed from RNA isolated from E10.5 control and
Hand1 point mutant heads (Fig. 4J). Results confirm qualitative
observations, showing that Fgf8, Spry1 and Etv5 are significantly
upregulated (*P≤0.05; **P≤0.01 n≥4) in both Hand1+/PO4− and
Hand1+/PO4+ phospho-mutant embryos when compared with
controls. Interestingly, both Etv5 and FgfR1 expression are elevated
inHand1+/PO4−mutants but not inHand1+/PO4+mutant embryos, and
we observe no significant difference in Etv4 expression (Fig. 4J).
In light of the expanded Fgf8 expression, we next examined Shh
signaling in Hand1 phospho-mutant embryos. Shh is known to act
synergistically with Fgf8 to drive cartilage outgrowth and cranial
formation (Abzhanov and Tabin, 2004). Moreover, expanded Shh
signaling is associated with a widening of the head (Abzhanov et al.,
2007; Brugmann et al., 2006; Cobourne et al., 2009; Hu et al., 2003;
Huang et al., 2007; Jeong et al., 2004; Jiang et al., 2006; Lan and
Jiang, 2009). Hand1 phospho-mutants exhibit a similar head
expansion between the nasal pits (supplementary material Fig. S1).
At E9.5, expanded expression of Shh is observed within Hand1
phospho-mutant embryos when compared with controls (Fig. 5A-E,
white asterisks). E11.5 control embryos (Fig. 5F) show undetectable
Shh expression within the medial head ectoderm of the sinus
cavity region, although robust expression is observed in the tooth
primordia. By contrast, Shh expression is persistent in the sinus cavity
of Hand1 phospho-mutant embryos (Fig. 5G-K, white arrows) in
addition to the tooth primordia (tp). Persistent Shh medial head
ectoderm expression is observed up to E12.5 (Fig. 5K-O), with
removal of the Hand1 wild-type allele reducing the observed
persistent expression. Additionally, strong Shh E12.5 expression is
observed within the forming tooth primordia, rugae (r) and mystacial
vibrissae (mv).
We next looked at the expression of patched 1 (Ptch1) in E9.5
embryos (Fig. 6A-C). When compared with control embryos, Ptch1
expression appears unchanged in the forming head mesenchyme
and first arch (black asterisk) of both Hand1+/PO4−;Wnt1-Cre(+) and
Hand1+/PO4+;Wnt1-Cre(+) embryos. Enhanced PA expression (black
asterisk) of the Shh-regulated transcription factor Gli1 is observed in
Hand1 heterozygous phospho-mutants; however, no significant
changes are observed in the expression of Gli3 (Fig. 6D-I). To
confirm these observations, we performed qRT-PCRonHand1+/PO4−;
Wnt1-Cre(+) and Hand1+/PO4+;Wnt1-Cre(+) phospho-mutant head
cDNA (Fig. 6J). Results confirm that both Shh andGli1 expression are
significantly enhanced in both Hand1 phospho-mutants; however,
Ptch1 and Gli3 expression levels are not significantly affected.
Collectively, these data demonstrate non-cell-autonomous changes in
both Fgf8 and Shh signaling pathways in Hand1 phospho-mutant
embryos.
Expression of Twist1 is altered in Hand1 phospho-mutant
embryos
As Twist1 is a known integrator of Fgf and Shh signaling (Hornik
et al., 2004), we next investigated the expression of Twist1 in
control and Hand1 phospho-mutant embryos (Fig. 7). Twist1 loss-
of-function mutations are associated with craniofacial defects
during embryogenesis (Chen and Behringer, 1995) and the disease
SCS (Barnes and Firulli, 2009; Firulli et al., 2005; Jabs, 2004). At
E10.5, Twist1 is robustly expressed within the NCC of the medial
and lateral nasal processes (lnp), the maxillary process (mp), as well
as the first (I) and second (II) PAs (Fig. 7A). In E10.5 Hand1
phospho-mutant embryos, the Twist1-expressing tissues are visibly
reduced in size, including the maxillary process (Fig. 7B-E, white
arrows), the medial and lateral nasal processes (Fig. 7B-E) and the
visibly smaller first and second PAs (Fig. 7B-E, asterisks). The
frontal view of E11.5 control embryos shows the correct
juxtaposition of the medial and lateral nasal processes, whereas
the Hand1 phospho-mutant embryos show an obvious reduction of
Twist1-expressing mesenchyme (black arrows) within both the
lateral and medial nasal processes of Hand1 phospho-mutant
embryos (Fig. 7F-J) and in the sinus cavity (Fig. 7P-T, asterisks),
suggesting a loss of tissue. As expression levels of Twist1 mRNA
do not appear uniformly reduced, we employed qRT-PCR analysis
to quantitate the Twist1 levels more accurately (Fig. 7U). Results
show that indeed the levels of Twist1 are significantly increased in
both E10.5 Hand1+/PO4− and Hand1+/PO4+. Thus, it appears that a
loss of tissue is responsible for the altered Twist1 expression
pattern and that Twist1 expression in both the remaining NCC-
and non-NCC-derived mesenchyme is increased in Hand1
phospho-mutants.
Fig. 4. Expression of Fgf8 downstream responders Spry1 and Etv5 at
E10.5. (A-I) Hand1 phospho-mutant embryos and the Fgf8 receptor FgfR1.
Control (A,D,G), Hand1+/PO4− (B,E,H) and Hand1+/PO4+ (C,F,I) were assayed
for Spry1 (A-C), Etv5 (D-F) and FgfR1 (G-H) by whole-mount ISH. White
asterisks denote enhancedSpry1 expression within the first mandibular arches
of Hand1 phospho-mutants. Black arrowhead in D shows the more robust
rostral versus caudal Etv5 expression within the first mandibular arch. White
arrowheads in E and F show caudal expansion of expression in both
Hand1+/PO4− and Hand1+/PO4+ phospho-mutants. I, first pharyngeal arch; op,
olfactory pit. (J) Comparison of FgfR1 expression between controls and
phospho-mutants. qRT-PCR analysis of Fgf8, Spry1, FgfR1, Etv5, Etv4. Error
bars denote s.e.m.; *P≤0.05 and **P≤0.01 by Student’s t-test. n≥4 for each
genotype.
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Inhibition of Shh signaling partially rescues Hand1 phospho-
mutant mid-face clefting
Given the upregulation of Fgf8, Shh and Twist1, we reasoned that
we could improve the mid-face clefting phenotype by reducing the
gene dosage of Twist1. To test this, we crossed the Hand1+/PO4+;
Wnt1-Cre(+) alleles onto the Twist1fx allele and looked for
improvement of mid-face clefting at E11.5 (Fig. 8A-F). Results
show no improvement to mid-face clefting in Hand1+/PO4+;
Twist1fx/+;Wnt1-Cre(+) embryos, and Hand1+/PO4+;Twist1fx/−;
Wnt1-Cre(+) superimposes Twist1-mediated exencephaly (Chen
and Behringer, 1995; Soo et al., 2002) on theHand1 phospho-mutant
clefting phenotype (Fig. 8E,F). We also reasoned that Hand2
expression levels could influence the Hand1 phospho-mutant
phenotypes. We therefore crossed Hand1fx/PO4−;Wnt1-Cre(+) mice
onto the Hand2+/neo background; however, lowering Hand2 gene
dosage had no visible effects on Hand1 phospho-mutant craniofacial
phenotypes (Fig. 8G-I).
We next reasoned that inhibition of Shh signaling could potentially
improve Hand1 phospho-mutant mid-face clefting, so we injected
pregnant dams with cyclopamine (Kasberg et al., 2013; Lipinski
et al., 2008) to antagonize Shh pathway activation and harvested
embryos at E13.5 and E14.5 (Fig. 8J-U). Partial phenotype rescue is
observed in the most severe Hand1+/PO4−;Wnt1-Cre(+) mutant
phenotype (three out of 15 mutant embryos isolated), as compared
with the 100% penetrance of pronounced mid-face clefting observed
in Hand1+/PO4−;Wnt1-Cre(+) mice (Fig. 8I,L,M,R,S). The least
severe Hand1PO4+/fx;Wnt1-Cre(+) mutants show more efficient
rescue (seven out of nine mutants; Fig. 8N,O,T,U). It is established
that abnormally low and high levels of Shh can also result in facial
abnormalities (Lipinski et al., 2010), and the improved phenotype
observed further supports the notion that the increased Shh level
observed in Hand1 phospho-mutants contributes directly to the
mid-face cleft phenotype.
DISCUSSION
The bHLH transcription factor Hand1 is clearly dispensable for
craniofacial formation (Barbosa et al., 2007). However, altering the
phosphoregulationofHand1,which influences its bHLHdimerization,
within the distal-most pharyngeal arch mesoderm results in a severe
non-cell-autonomous increase in PA NCC death that ultimately
manifests in a mid-face cleft phenotype. In addition to increased cell
death, essential signaling pathways required for proper craniofacial
morphogenesis (Fgf8 and Shh) show expanded expression in Hand1
phospho-mutant embryos. Treatment in uterowith the Shh antagonist
cyclopamine can improve the severity of the resultant mid-face cleft
(Fig. 8), thus supporting the hypothesis that the increases observed in
these signaling pathways drive the resultant phenotype.
Hand1 expression is observed only within the most distal arch
mesenchyme and becomes detectable betweenE9.0 andE9.5 (Fig. 1;
Firulli et al., 1998; Ruest et al., 2004). As the Hand1PO4− and
Hand1PO4+mutants are knock-in alleles, theseHand1 dimermutants
are expressed at endogenous levels in a spatio-temporal pattern
consistent with wild-typeHand1. At E9.5,Hand1 phospho-mutants
display robust pathological cell death in the PAs, indicating that the
deleterious effects from the expression of themutant allele are nearly
immediate within the arch mesenchyme. Indeed, phenotypic
changes are present by E10.5 (supplementary material Fig. S1).
Histological analysis indicates that right and left structures are
essentially normal, although, due to the loss of tissue from the early
cell death, the outgrowth of the right and left sides of the forming face
fail to fuse (supplementary material Fig. S2). This conclusion is
supported by the normal expression of the fusion markers jagged 2
(Jag2) and matrix metallopeptidase 13 (Mmp13) (supplementary
material Fig. S4) and the direct initiation of fusion observed in
Hand1PO4+/fx;Wnt1-Cre(+) embryos (Fig. 1N; supplementary
material Fig. S2), which exhibit the least amount of early cell
death and a less severe phenotype. Additionally, by utilizing the P0-
Cre mouse strain to activate Hand1 mutant allele expression within
the NCC during their migration [a full day later than Wnt1-Cre
allelic activation (Yamauchi et al., 1999)], the severity and
penetrance of the mid-face cleft is greatly reduced (supplementary
material Fig. S6). This reinforces the idea that the deleterious
effects of Hand1 phospho-mutant proteins are immediate to their
expression and that even a subtle delay in expression largely limits
Fig. 5. Shh craniofacial expression in Hand1 phospho-mutant embryos in ventral view. At E9.5 (A-E), E11.5 (F-J) and E12.5 (K-O), control (A,F,K),
Hand1+/PO4− (B,G,L), Hand1PO4−/fx (C,H,M), Hand1+/PO4+ (D,I,N) and Hand1PO4+/fx (E,J,O) were assayed for Shh expression by whole-mount ISH. White
asterisks indicate enhancedShh expression in themedial headmesenchyme at E9.5 (B-E). (F-O) By E11.5,Shh expression is restricted to the tooth primordia (tp)
and esophagus (es) of control embryos. White arrows indicate persistent Shh expression in mutant embryos both at E11.5 and E12.5. Shh expression in control
mystacial vibrissae (mv, black arrowhead) and rugae (r) is also observed normally in both controls and mutants (not visible). n≥4 for each genotype.
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the observed phenotype. Combined, these data demonstrate that
Hand1 phospho-mutant facial structures are capable of fusion
and, considering the lack of significant changes in cell
proliferation, suggest that a non-cell-autonomous increase in
arch mesenchyme cell death causes these phenotypes. Given that
reduced cell death is observed in the distal most arch mesenchyme
where the Hand1 dimer mutants are expressed (Fig. 2), it is
probable that Hand1 phospho-mutants interfere with other bHLH
dimer choices within this limited Hand1 expression domain.
Consequently, this causes the non-cell-autonomous cell death,
leading directly to the changes in Fgf8 and Shh signaling pathway
expression and ultimately resulting in the defects in the upper
bones of the skull. Outside the Hand1 expression domain, we
observe a loss of Twist1-expressing tissue but an increase in
Twist1 expression (Fig. 7), which could lead to increased
formation of Twist1 homodimers. Indeed, increased Twist1
homodimer expression is directly associated with premature
ossification and suture fusion accompanied by enhanced Fgf
signaling (Connerney et al., 2006, 2008). Conversely, later-stage
deletion of Twist1 using Tyr-Cre also yields a mid-faced cleft
(Bildsoe et al., 2009), reinforcing the notion that altered gene
dosage in conjunction with dimer choice can dramatically effect
development. In genetic experiments, lowering the gene dosage
of Twist1 on the Hand1+/PO4− background does not improve the
mid-face phenotype, and complete NCC conditional knockout of
Twist1 on the Hand1+/PO4− via Wnt1-Cre results in a more severe
phenotype than either mutant separately (Fig. 8).
Another possible interpretation of these findings is that a bHLH-
dependent distal arch-signaling center could integrate Fgf8 and Shh
signalingpathways.The incongruityof the tightly restricted domain of
Hand1 within the distal midline of the first mandibular PA and the
alterations in gene expression observed in Hand1 phosphoregulation
mutants is consistent with the ‘Hinge and Caps’ model proposed by
Depew (Compagnucci et al., 2013; Depew and Compagnucci, 2008;
DepewandSimpson, 2006; Fish et al., 2011). In thismodel, reciprocal
signaling between the putative ‘Hinge’, or the oral ectoderm of the
proximal first PA, and two ‘Caps’ [corresponding to (1) the medial
frontonasal processes and (2) the distal mandibular midline] pattern
the nascent jaw along the proximo-distal, medio-lateral and rostro-
caudal axes. This reciprocal signaling could explain how altered
bHLH-dependent transcriptional mechanisms within the distal
mandibular midline can alter gene expression profiles non-cell
autonomously within the medial frontonasal processes and cause
ectopic cell death within the proximal first arch. We can rule out the
alternative possibility of cell migration from regions of Hand1
expression in the mandibular arch to the maxillary prominence, as
Hand1Cre lineage analysis shows that Hand1 daughter cells do not
enter the maxillary prominence (Barnes et al., 2010).
Initially, we were surprised by the observation that both the
hypophosphorylated andphosphorylation-mimickingHand1mutants
exhibit a less severe phenotype when the wild-type Hand1 allele is
deleted. This observation highlights the mechanics of bHLH factors
and their prerequisite homodimeror heterodimer formation conveying
transcriptional activity on target genes. It is clear that complete
Fig. 6. Expression of Shh downstream responders Ptch1,
Gli1 and Gli3 expression in E10.5 control and Hand1 phospho-
mutant embryos. (A-C) Ptch1 expression appears unaffected in
the first pharyngeal arch. (D-F) Gli1 expression within the first
pharyngeal arch is also enhanced (marked by asterisks).
(G-I) Comparison of Gli3 expression between control and Hand1
phospho-mutant embryos reveals no significant changes in
expression. (J) qRT-PCR analysis of Shh, Ptch1, Gli1 and Gli3
expression. Error bars denote s.e.m.; *P≤0.05 and **P≤0.01 by
Student’s t-test. n≥4 for each genotype.
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deletion ofHand1 does not significantly affect the bHLH dimer pool
within the distal mesenchyme, as such Hand1 loss-of-function
mutants are phenotypically normal, viable and fertile (Barbosa et al.,
2007). The absence ofHand1-mediated defects might be the result of
functional compensation by the related bHLH factorHand2within the
cranial NCC. This is an established mechanism that functions in both
sympathetic neurons and the developing heart (Barbosa et al., 2007;
Hendershot et al., 2008; Howard, 2005; McFadden et al., 2005;
Vincentz et al., 2012). By contrast, alteringHand1 phosphoregulation
alters the ability of Hand1 to interact with potential bHLH dimer
partners (Firulli et al., 2003). By interfering with the function of other
crucial bHLH factors via direct dimerization and/or by titration of
available E-protein levels, the result is a dramatic increase in PA cell
death. The finding that wild-type Hand1, in the presence of the
Hand1 phospho-mutant alleles, contributes to these deleterious
transcriptional effects when the bHLH dimer pool is altered further
confirms the role of Hand gene dosage phenotypes that are well
established in a numberof developmental systems, including the heart
and limbs (Barbosa et al., 2007; Firulli et al., 2010, 2005; McFadden
et al., 2005). The complexity of regulating the bHLH pool lies in
determining all combinations ofHand bHLHdimer complexeswithin
the extremely narrow temporal window when this dysfunction is
occurring. Additionally, we have to consider that altering the Twist-
family dimer regulation also affects DNA-binding affinities (Firulli
et al., 2007). Therefore, it is also possible that Hand1 mutant proteins
could target promoters inappropriately and/or facilitate other bHLH
factors to do likewise, thus further effecting gene expression.
MATERIALS AND METHODS
Mouse strains, genotyping and cyclopamine injections
Hand1stopfloxHand1T107;S109A (Hand1PO4−) andHand1stopfloxHand1T107;S109D
(Hand1PO4+) micewere generated from embryonic stem cells targeted with
the constructs described in Fig. 1. Genotyping was performed by Southern
blot as described previously (Firulli et al., 1998), or with the allele-specific
primers H1 (5′-CTGCCATTGGCTCCGGCTAGAGGT-3′) and PGK (5′-
GGCTGCTAAAGCGCATGCTCCAGACTG-3′), using PCR conditions of
94°C for 1 min, 60°C for 1 min and72°C for 1 min for 35cycles.B6.129S4-Gt
(ROSA)26Sortm1Sor/J (ROSA26R-β-gal homozygous; R26RlacZ) mice were
genotyped using a probe located 5′ of the Stop-Flox (provided byDr Phillippe
Soriano, Mount Sinai Hospital). Both Hand1+/PO4− and Hand1+/PO4+ alleles
were bred onto a R26RlacZ homozygous background, and females of this
genotype were crossed to Wnt1-Cre [Tg(Wnt1-cre)2Sor] (Danielian et al.,
1998) or Wnt1-Cre(+);Hand1fx/fx males to generate either Hand1+/PO4 or
Hand1fx/PO4 embryos.RARE-lacZmice [Tg(RARE-Hspa1b/lacZ)12Jrt/J] were
obtained from the Jackson Laboratories. P0-Cremice (Yamauchi et al., 1999)
were obtained from Simon J. Conway (Indiana University, USA).
Cyclopamine (Sigma) was resuspended at 1 mg/ml in 45% w/v solution in
water 2-hydroxpropyl-beta-cyclodextrin solution and administered at a dosage
of 20 mg/kg bodyweight twice daily to pregnant dams at E8.5-E10.5 via
intraperitoneal injection.
Histology
Embryos (E9.5-E18.5) were fixed in 4% paraformaldehyde, dehydrated,
embedded, sectioned and Hematoxylin and Eosin (H&E) stained as
described (Firulli et al., 2010). A minimum of four viable embryos per
genotype was used for all analyses. All data were collected on a Leica
DM5000 B compound fluorescence microscope.
ISH-qRT-PCR
Digoxygenin (DiG)-labeled section and whole-mount ISHs were carried
out as described (Barnes et al., 2011; Firulli et al., 2010; Vincentz et al.,
2008). qRT-PCR was performed on a LightCycler 480II (Roche) using
TaqMan primers (Life Technologies) recognizing the following
transcripts: Fgf8, Spry1, Fgfr1, Etv5, Etv4, Shh, Ptch1, Gli1, Gli3 and
Twist1. Heads cut between the first and second PAs from viable embryos
were flash-frozen for RNA isolation and genotyped from the yolk sacDNA.
Total RNA was isolated using a High Pure RNA Tissue Kit (Roche) and
cDNA was prepared using a High-Capacity cDNA Reverse Transcription
Kit (Life Technologies) following the manufacturer’s protocol. Error bars
denote s.e.m. Statistical significancewas determined using Student’s t-test.
P-values ≤0.05 were regarded as significant and marked in all graphs by a
Fig. 7. Twist1 craniofacial expression in Hand1 phospho-mutant embryos. At E10.5 (A-E), E11.5 (F-O) and E12.5 (P-T), control (A,F,K,P), Hand1+/PO4−
(B,G,L,Q), Hand1PO4−/fx (C,H,M,R), Hand1+/PO4+ (D,J,N,S) and Hand1PO4+/fx (E,J,O,T) were assayed for Twist1 expression by whole-mount ISH. (A) E10.5
control, embryos show strong Twist1 expression within the lateral nasal process (lnp) and maxillary process (mp), as well as first (I) and second (II) PAs. (B-E) In
Hand1 phospho-mutants, Twist1 expression is visibly reduced within both PAs and the maxillary process (white arrow). Frontal views of E11.5 control (F) and
mutant (G-J) embryos show a reduced level of expression within the medial nasal process (mnp) as well as a loss of medial expression between the olfactory pits
(demonstrated by white line in G). Ventral views of F-J show Twist1 expression within the head mesenchyme. E12.5 control (P) and Hand1 phospho-mutant
heads (Q-T). (U) qRT-PCR analysis of Twist1 expression. Error bars denote s.e.m.; *P≤0.05 and **P≤0.01 by Student’s t-test. n≥4 for each genotype.
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single asterisk, andP-values≤0.01 are denoted by a double asterisk. n≥4 in
all experiments.
TUNEL, LysoTracker and EdU immunohistochemistry analysis
TUNEL analysis on sectioned embryos was performed as described (Firulli
et al., 2010). LysoTracker (Life Technologies) was incubated with embryos
as per the manufacturer’s instructions. Embryos were imaged in a well slide.
Cell proliferation was assayed using the Click-IT EdU Imaging Kit (Life
Technologies). Pregnant dams were injected with EdU (200 mg/kg body
weight) 1 h prior to embryo harvest.
Micro-CT and skeletal preparations
Craniofacial morphology of P0 mice was assessed using high-resolution
desktop X-ray microtomography (micro-CT) SkyScan 1172 imaging system
(SkyScan). Skulls were dissected, fixed in 10% neutral buffered formalin
and stored in 70% ethanol. Skulls were scanned with an isotropic voxel size
of 8 µm, with an energy level of 50 kV and an aluminum 0.5 mm filter.
A lower energy source was used to capture regions of undermineralized
bone. Two-dimensional (2D) cross-sectional grayscale slices (∼600-800
slices per skull) from each skull were reconstructed using NRecon
reconstruction software (SkyScan). Reconstructed slices were saved as
individual TIFF images and converted to a DICOM (Digital Imaging and
Communications in Medicine) format. DICOM files were used to create 3D
models using OsiriX version 5.6, imaging processing software for DICOM
images (Medical Imaging Software). All 3D images were created using
identical grayscale thresholds, with scaling of each image conserved.
Overlaying skeletal structures were removed using a bone removal tool to
identify structures of the palate (Fig. 1). n≥4 per genotype scanned and
reconstructed. Measurements of bones were performed on all scanned heads
and significance (P≤0.05) determined by Student’s t-test. Skeletal
preparations were performed as described (Firulli et al., 2005).
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Supplementary Figure 1: Wholemount views of control (A-F), Hand1+/PO4- (G-L), Hand1PO4-/fx (M-R), Hand1+/PO4+ (S-X), and 
Hand1PO4+/fx (Y-Zd) embryos between E10.5 and E18.5. At E10.5 visible differences in facial structures are observed be-
tween controls (A) and phospho mutants (G, M, S, Y) including measure of the distance between the olfactory pits (op; black 
lines), size of maxillary process (mp) and frontal, lateral and distal nasal processes (fnp, lnp, mnp) though no significant dif-
ference is observed in mandible (md) size. In E11.5 controls (B) the left and right distal nasal process begins to meet at the 
midline, bringing the olfactory pits closer together. In Hand1 phospho mutants (H, N, T, Z) the distance between the olfactory 
pits does not decrease. The extent of mid-face clefting is patently obvious at E12.5 (compare C with I, O, U, Za) where the 
tongue (t) is clearly visible through the cleft. Facial defects progressively become more pronounced at E14.5 (compare D 
with J, P, V, Zb). Top view of E18.5 controls (E) show the nasal capsule (nc) completely fused where as phospho mutants 
maintain unfused nasal capsules (K, Q, W, Zc asterisks). Ventral views reveal a near complete loss of the secondary palate 
(compare F with L, R, X, Zd; black arrows). n≥4 for each genotype.
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Supplementary Figure 2: Histological analysis of Hand1 phospho mutants at E14.5. Frontal (A-E) and transverse (F-J) 
sections of Control (A, F) Hand1+/PO4- (B, G), Hand1PO4-/fx (C, H), Hand1+/PO4+ (D, I), and Hand1PO4+/fx (E, J) embryos. Frontal 
sections show that the tongue (t) fails to drop and that the palatal shelves (ps) fail to fuse (marked by asterisk). Tooth Pri-
mordia (tp) meckel’s cartilage (mc) and other structures appear normally formed albeit displaced in location. Transverse 
sections show that the nasal cavities (nc) form in the phospho mutants; however, the nasal septum is absent from facial 
structures. n≥4 for each genotype.
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Supplementary Figure 3: Analysis of NCC migration in Control, Hand1+/PO4-, and Hand1+/PO4+ embryos on the R26R back-
ground. Lateral views of E9.5 day Control (A), Hand1+/PO4- (B), and Hand1+/PO4+ (C), show no significant changes in the 
Wnt1-Cre activation of β-galactosidase within the NCC. Lateral views at E11.5, robust and indistinguishable numbers of 
reporter-marked NCC are observed in all of the pharyngeal arches and cardiac outflow tract (oft) of both Control and phos-
pho-mutant embryos. (G-I) show transverse sections confirming the presence of β-galactosidase-marked NCC within the 
OFT. Pharyngeal arches are indicated by roman numerals; left ventricle (lv), atria (a). Somite numbers are indicated in the 
lower right hand corners of each panel. n≥4 for each genotype.
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Supplementary Figure 4: E14.5 section in situ hybridization analysis of the fusion markers Mmp13 and Jagged 2 in control 
(A and D), Hand1+/PO4- (B and E), and Hand1+/PO4+ (C and F) embryos. Control sections show the initiation of fusion of the 
palatal shelves (ps) just dorsal to the olfactory pits (op). Mmp13 expression marks the surrounding epithelium of the palatal 
shelves as well as the cells surrounding the nasal septum. In Hand1 phospho-mutant embryos Mmp13 expression patterns 
are not significantly different. Similarly Jagged2 expression mirrors that of Mmp13 in both control (D) and phospho mutants 
(E and F). n≥4 for each genotype.
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Supplementary Figure 5: β-Galactosidase activity showing expression of the Retinoic Acid Reporter Element (RARE) lacZ 
reporter in Control (A, D, G), activated Hand1+/PO4- (B, E, H), and Hand1+/PO4+ (C, F, I) backgrounds. E10.5 Phospho mutants 
show a reduction in frontal nasal process (fnp) tissue; however the RA signaling underlining the tissue is largely unaffected. 
Similarly at E11.5 no significant difference in RA-induced β- Galactosidase staining is evident in between control (G) Hand1 
phospho mutants (H and I). Black arrows point to the forming mid-face cleft. n≥4 for each genotype.
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Supplementary Figure 6: Activation of Hand1 phospho-mutant expression using P0-Cre reduces the severity of cranio-
facial phenotypes. The P0-Cre transgene is expressed in migrating NCCs becoming active a day later than the Wnt1-Cre 
transgene. (Yamauchi et al., 1999) Comparison of E18.5 day control (A and B) and activated Hand1+/PO4- (C and D) heads 
show that fusion of the nasal capsule (nc) is nearly complete though still not phenotypically normal. Nasal bones (nb) and 
frontal bones (fb) are reduced in size and the white bar marks the gap between the left and right frontal bonds, which is 
absent in controls. Ventral views (B and D) reveal that palate formation in the Hand1+/PO4- embryo is vastly improved. As the 
P0-Cre transgene is expressed within the pharyngeal arch NCC mesenchyme nearly concurrently with Hand1, the obvious 
temporal delay of deletion of the Stop-flox cassette supports the data in Figure 2 suggesting that the deleterious effects of 
Hand1 phospho-mutant expression are immediate upon its initial activation. Trachea (t) is labeled in ventral views. n≥4 for 
each genotype.
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Supplementary Table 1. Skeletal lengths and area measurements from Micro-CT scanning. 
Skeletal Region                           WT         A+                          A-                           D+                       D- 
Mandible Area (mm2)          5.698 ± 0.158¥        3.170 ± 0.158*       5.088 ± 0.194*¥       4.718 ± 0.158*¥      4.721 
± 0.194*¥ 
Mandible Length (mm)         5.021 ± 0.059¥        3.442 ± 0.059*       4.331 ± 0.073*¥       4.108 ± 0.059*¥       4.168 
± 0.073*¥  
Tympanic Length (mm)       2.014 ± 0.114¥        0.609 ± 0.114*       1.996 ± 0.139¥         1.760 ± 0.114¥   1.507 
± 0.139*¥   
Premaxilla Area (mm2)       1.546 ± 0.094       0.690 ± 0.094*        0.862 ± 0.115*¥       0.958 ± 0.094*       0.940 
± 0.115* 
Premaxilla Length (mm)       1.970 ± 0.078¥         1.141 ± 0.078*        1.302 ± 0.095*         1.545 ± 0.078*¥     1.552 
± 0.095*¥ 
Zygomatic arch Length (mm)   4.329 ± 0.102¥      1.843 ± 0.102*      3.573 ± 0.125*¥     3.412 ± 0.102*¥     3.202 
± 0.102*¥    
Squamous Area (mm2)           0.638 ± 0.030¥      0.021 ± 0.030*     0.280 ± 0.037*¥     0.198 ± 0.037*¥    0.235 
± 0.030*¥  
Palate Left Area (mm2)           0.952 ± 0.072¥      0.134 ± 0.072*      0.650 ± 0.089*¥     0.552 ± 0.072*¥    0.727 
± 0.089¥ 
Palate Right Area (mm2)        0.934 ± 0.050¥      0.188 ± 0.050*      0.576 ± 0.061*¥     0.647 ± 0.050*¥     0.797 
± 0.061¥  
Basisphenoid Area (mm2)       1.220  ± 0.064     0.375 ± 0.064*     0.626 ± 0.078*¥     0.583 ± 0.476*¥    0.476 
± 0.078*       
Presphenoid Area (mm2)     0.816 ± 0.108     0.627 ± 0.108     1.478 ± 0.133*¥    1.168 ± 0.108*¥   0.952 
± 0.133   
Pterygoid Left Area (mm2)    0.194 ± 0.018¥     0.024 ± 0.018*    0.109 ± 0.022*    0.149 ± 0.018*     0.191 
± 0.022* 
Pterygoid Right Area (mm2) 0.191 ± 0.027¥    0.017  ± 0.027*    0.097 ± 0.032     0.136 ± 0.027¥    0.204 
± 0.032¥ 
Incisor Distance (mm)       0.184 ± 0.262¥      2.465 ± 0.262*    1.892 ± 0.321*      0.873 ± 0.262¥     0.849 
± 0.321¥    
Palate Distance (mm)   0.866 ± 0.170¥     2.113 ± 0.170*      1.969 ± 0.208*      1.511 ± 0.170*¥     1.083 
± 0.208¥  
*Significantly different from WT; ¥significantly different from A+ 
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